Article
New tuberculosis drug enters human trials
Lancet Infectious Diseases
Publication Date
8-1-2005
Document Type
Article
Disciplines
Abstract
The Global Alliance for TB Drug Development (TB Alliance) and its partners have begum testing an experimental drug—PA-824. “[The drug's] excellent profile means its introduction into a new regimen could help shorten treatment time dramatically and overcome some of the challenges with tuberculosis treatment, such as multidrug resistance and the treatment of tuberculosis/HIV co-infected patients”, Mel Spigelman of the TB Alliance explained.
Citation Information
Khabir Ahmed. "New tuberculosis drug enters human trials" Lancet Infectious Diseases Vol. 5 Iss. 8 (2005) p. 475 Available at: http://works.bepress.com/khabir_ahmed/56/